Growing adoption of preventive healthcare is creating opportunities in the Cardiometabolic Disease Market. Routine screening for blood pressure, glucose levels, cholesterol, and body weight can enable earlier identification of patients at elevated cardiometabolic risk. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in 2025, registering...